Pink Basic Disclosure Guidelines News Today

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines The Monarch Cement Company A Kansas Corporation ...

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Infrax Systems Inc. ... | February 14, 2022

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Vortex Brands Co. 3511 Del Paso Rd., Ste. 160 PMB 432 ... | January 8, 2022

Isclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Amended Mogul Energy International, Inc. 2500... | December 18, 2021

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Amended Mogul Energy International, Inc. 2500... | December 18, 2021

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Amended Mogul Energy International, Inc. 2500... | December 18, 2021

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Clifton Mining Company 705 East 50 South, American Fork, UT 84003 ... | November 21, 2021

Share this article Share this article LAS VEGAS, May 10, 2021 /PRNewswire/ -- GNCC Capital, Inc. (GNCP.PK) ("The Company" or "GNCC") confirms that external Counsel has completed his extensive review and prepared the amended Attorney Letter. This being in respect of the below-mentioned Annual and Quarterly Reports and was filed on May 9, 2021 and dated May 8, 2021. A link: https://backend.otcmarkets.com/otcapi/company/financial-report/282161/content Annual Report for the year ended September 30...

Share this article Share this article LAS VEGAS, April 23, 2021 /PRNewswire/ -- GNCC Capital, Inc. (GNCP.PK) ("The Company" or "GNCC"), following a review by OTC Market Compliance Department; has today amended and refiled, as follows:- Annual Report to September 30, 2019; and Annual Report to September 30, 2020; and Quarterly Report for First Quarter to December 31, 2020; and Quarterly Report for Second Quarter to March 31, 2021 Each of these Reports were accompanied by the extensive "Disclosu...

Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application Third Tranche of $1.2 Million Financing Completed COLLEGE STATION, TX / ACCESSWIRE / January 19, 2021 / Enzolytics, Inc. (OTC PINK:ENZC)(the "Company") today, announced it has received the official filing receipt from the U.S. Patent Office confirming the filing of its patent application for "Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor - Pharmaceutical Composition for Treatment" an...